Treatment of chronic conditions "biggest hurdle" facing switches -- ex-NDAC chair Juhl.
This article was originally published in The Tan Sheet
Executive Summary
CHRONIC CONDITION TREATMENT "BIGGEST HURDLE" FACING Rx-to-OTC SWITCHES today, former FDA Nonprescription Drugs Advisory Committee Chair Randy Juhl, PhD, University of Pittsburgh, told attendees of the Ohio Pharmaceutical Seminar in Columbus April 21. Noting most OTCs are for acute conditions, Juhl questioned whether consumers should have the ease of over-the-counter access to a drug they may take for many years.